Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain expressed X-linked protein 1 (BEX1) is an intrinsically disordered protein encoded by the BEX1 gene located on the X chromosome and primarily expressed in the brain, as well as testis, pancreas, and other tissues[1][3]. BEX1 functions as a signaling adaptor and transcriptional co-regulator, enabling binding to transcription factor complexes and facilitating positive regulation by RNA polymerase II[1][5]. It plays key roles in cell cycle progression, neuronal differentiation—in particular, acting as a modulator of neurotrophic signaling through p75 neurotrophin receptor (p75NTR/NGFR)—and mRNA stabilization as part of ribonucleoprotein complexes[2][3][5]. BEX1 is involved in tissue regeneration, neural repair (for example, upregulation after nerve injury to promote axon regeneration), and cellular differentiation, with context-dependent effects on proliferation or differentiation[1][3]. Aberrant expression or function of BEX1 has been implicated in several diseases, particularly in the context of cancer progression and as a novel factor induced in cardiac pathology, where it promotes inflammatory gene expression through direct mRNA interaction in cardiomyocytes[2][5]. Molecularly, it interacts with numerous RNA processing and transport proteins, including DDX3x, EPRS, and MAP4, but has no known enzyme activity or traditional receptor function[2]. At present, neither drugs targeting BEX1 nor validated uses as a biomarker for patient stratification or therapy monitoring have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain expressed X-linked protein 1 (BEX1).